FDA Inspection
Qingdao BAHEAL Pharmaceutical Co.,Ltd.Qingdao BAHEAL Pharmaceutical Co.,Ltd. – FDA Inspection, Dec 6, 2019
Record Details
This FDA Inspection record concerns Qingdao BAHEAL Pharmaceutical Co.,Ltd., with an inspection on December 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 6, 2019
- Product Type
- Drugs
View Company Profile
ID · d37f9f84-2b56-47ba-b6ed-103d4250a369
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1114238
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Qingdao BAHEAL Pharmaceutical Co.,Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2017 | Not classified | Office of Inspections and Investigations | |
| October 21, 2016 | Not classified | Office of Inspections and Investigations |
Other documents for Qingdao BAHEAL Pharmaceutical Co.,Ltd.
- FDA Inspection 1237545 - 2024-03-22
- FDA Inspection 1032012 - 2017-09-29
- FDA Inspection 991461 - 2016-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.